Delek Group’s CVS Health CVS Stock Holding History

Delek Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1.56M	Buy	29,295 +794	+3%	+$42.8K	0.06%	154
2019 Q1	$1.53M	Buy	+28,501	New	+$1.76M	0.06%	151

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Delek Group's CVS Position: Q2 2019 in Review

Delek Group increased its CVS Health (CVS) stake by 2.8% in Q2 2019, buying an estimated $42.8K and bringing the position to 29,295 shares worth $1.56M. The position accounts for 0.06% of the portfolio, ranked #154.

Delek Group first reported a position in CVS in Q1 2019 and has held it in 2 quarters since. 1,654 funds tracked by Wall St. Rank hold CVS as of Q2 2019.

Delek Group held 29,295 shares of CVS Health worth $1.56M as of Q2 2019.
Delek Group bought 794 CVS Health shares in Q2 2019, an estimated $42.8K.
CVS Health made up 0.06% of Delek Group's portfolio in Q2 2019, its #154 holding.
Delek Group first reported a position in CVS Health in Q1 2019 and has held it in 2 quarters since.
1,654 funds tracked by Wall St. Rank held CVS Health as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.